COVID-19 FAQ: Is survivors’ blood plasma an effective therapy against the illness?

Convalescent plasma (CP) therapy to treat hospitalised COVID-19 patients has received emergency use authorisation (EUA) from the FDA in the United States. This kind of therapy is a classic prevention and treatment strategy against infectious diseases that has been in use for many decades.